Swine Flu Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
Global Swine Flu Drugs Market: Overview
Swine flu is a respiratory disease originally transmitted from pigs to human beings, and presently even from one person to another. Symptoms of swine flu include vomiting, nausea, sore throat, runny nose, sneezing, coughing, diarrhea, chills, headaches, lethargy, fever, and lack of appetite. Swine flu cases become more prevalent during monsoon and summer seasons. People with weak or compromised immune systems, heart problems, or and diabetics, besides pregnant women and children, are at high-risk of swine flu. The incubation period of swine flu is approximately one day to four days. Diagnosis of swine flu is done in labs through the identification of antigens specifically associated with the H1N1 type A influenza virus. Drugs available for the treatment of swine flu include Tamiflu, Oseltamivir, Relenza, Zanamivir, and Peramivir. However, among swine flu drugs, Peramivir has not been approved by the FDA for the treatment of swine flu.
Global Swine Flu Drugs Market: Drivers and Restraints
Swine flu virus was for the first time isolated from pigs in the U.S. in 1930 and has been recognized to have caused infections among pigs all over the world. People who are closely associated with pigs, such as pork processors or farmers, tend to get affected with swine flu drugs. In many cases swine flu drugs cross infections that is human flu virus to pigs or swine virus to human beings has remained in the local areas. However, in Mexico, in April 2009, there was an outbreak (pandemic) of swine flu due to infection with the H1N1 virus. The term H1N1 flu was coined by the investigators as it was mainly found infecting human beings and exhibited two main surface antigens, H1 (hem agglutinin type 1) and N1 (neuraminidase type1). Swine flu has been spreading all over the world. Increase in prevalence of swine flu drives the growth of the swine flu drugs market. In Asia, for instance, India recorded approximately 1,094 deaths in 2017 caused by swine flu, as per a BBC news report. The report also stated that there were a total of 22,186 cases of swine flu testified across India.
Global Swine Flu Drugs Market: Key Segments
The swine flu drugs market can be segmented on the basis of drug class, dosage form, distribution channel, and region. Based on drug class, the swine flu drugs market can be categorized into neuraminidase inhibitors and inhaled anti-infectives. In terms of dosage form, the swine flu drugs market can be classified into capsule and oral powder inhalation. Based on distribution channel, the swine flu drugs market can be divided into online pharmacies, retail pharmacies, and hospital pharmacies. The hospital pharmacies segment was estimated to dominate the swine flu drugs market in 2016 owing to the wide availability of swine flu drugs in them.
Geographically, the swine flu drugs market can be divided into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. Asia Pacific accounted for the dominant swine flu drugs market share in 2016 due to increase in prevalence of swine flu in the region. Europe constituted the next leading share of the swine flu drugs market in 2016 owing to rise in infectious diseases among people with certain long-term health conditions, pregnant women, young children, and geriatric population. North America also held a significant share of the swine flu drugs market in 2016, due to increasing prevalence of the swine flu in the region. The swine flu drugs market in Middle East & Africa and Latin America is anticipated to expand during the forecast period.
Global Swine Flu Drugs Market: Key Players
Key players operating in the swine flu drugs market include Gilead Sciences, Inc., Genentech, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline, and BioCryst Pharmaceuticals, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017